Phibro Animal Health Stock Working Capital

PAHC Stock

USD 23.76 0.37 1.58%

Phibro Animal Health fundamentals help investors to digest information that contributes to Phibro Animal's financial success or failures. It also enables traders to predict the movement of Phibro Stock. The fundamental analysis module provides a way to measure Phibro Animal's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Phibro Animal stock.

	Last Reported	Projected for Next Year
Net Working Capital	396.8 M	363.5 M
Change In Working Capital	33.1 M	34.8 M

The current year's Change In Working Capital is expected to grow to about 34.8 M, whereas Net Working Capital is forecasted to decline to about 363.5 M.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Phibro Animal Health Company Working Capital Analysis

Phibro Animal's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .

Working Capital

Current Assets

-

Current Liabilities

More About Working Capital | All Equity Analysis

Current Phibro Animal Working Capital

396.85 M

Most of Phibro Animal's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Phibro Animal Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Phibro Working Capital Driver Correlations

Understanding the fundamental principles of building solid financial models for Phibro Animal is extremely important. It helps to project a fair market value of Phibro Stock properly, considering its historical fundamentals such as Working Capital. Since Phibro Animal's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Phibro Animal's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Phibro Animal's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Good Will	Net Tangible Assets	Current Deferred Revenue	Short Term Investments	Deferred Long Term Liab	Short Long Term Debt	Long Term Debt Total	Capital Surpluse	Long Term Investments	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.81	0.87	0.8	0.82	0.52	0.95	0.89	0.99	0.62	0.78	-0.13	0.96	0.95	0.79	0.03	0.73	0.26	-0.69	0.73	0.78	0.86	0.82	0.82	-0.09
Total Stockholder Equity	0.81		0.53	0.98	0.54	0.24	0.84	0.54	0.8	0.78	0.65	-0.55	0.76	0.87	0.94	-0.06	0.75	0.34	-0.79	0.54	0.84	0.93	0.82	0.83	-0.39
Net Debt	0.87	0.53		0.55	0.78	0.76	0.72	0.97	0.87	0.58	0.6	0.19	0.88	0.82	0.58	0.01	0.59	0.02	-0.39	0.83	0.66	0.64	0.79	0.76	-0.14
Retained Earnings	0.8	0.98	0.55		0.52	0.33	0.79	0.54	0.78	0.84	0.6	-0.51	0.76	0.87	0.93	-0.07	0.77	0.26	-0.73	0.61	0.87	0.92	0.86	0.86	-0.42
Accounts Payable	0.82	0.54	0.78	0.52		0.54	0.81	0.88	0.86	0.46	0.54	0.17	0.72	0.7	0.62	-0.22	0.39	0.19	-0.47	0.59	0.64	0.58	0.7	0.71	-0.15
Long Term Debt	0.52	0.24	0.76	0.33	0.54		0.36	0.69	0.54	0.52	0.15	0.27	0.61	0.57	0.33	-0.02	0.38	-0.47	0.17	0.81	0.51	0.27	0.68	0.63	-0.16
Net Receivables	0.95	0.84	0.72	0.79	0.81	0.36		0.77	0.96	0.57	0.68	-0.24	0.87	0.85	0.82	-0.01	0.63	0.29	-0.69	0.57	0.76	0.83	0.78	0.81	-0.09
Total Liab	0.89	0.54	0.97	0.54	0.88	0.69	0.77		0.9	0.53	0.64	0.27	0.86	0.8	0.61	-0.03	0.55	0.11	-0.47	0.74	0.67	0.65	0.74	0.73	-0.15
Total Current Assets	0.99	0.8	0.87	0.78	0.86	0.54	0.96	0.9		0.63	0.72	-0.07	0.94	0.92	0.81	0.0	0.71	0.25	-0.66	0.71	0.8	0.83	0.84	0.84	-0.12
Short Term Debt	0.62	0.78	0.58	0.84	0.46	0.52	0.57	0.53	0.63		0.25	-0.38	0.68	0.72	0.86	-0.22	0.7	0.04	-0.43	0.73	0.92	0.73	0.9	0.88	-0.73
Intangible Assets	0.78	0.65	0.6	0.6	0.54	0.15	0.68	0.64	0.72	0.25		-0.11	0.68	0.78	0.49	0.16	0.59	0.4	-0.79	0.37	0.42	0.75	0.41	0.39	0.14
Common Stock	-0.13	-0.55	0.19	-0.51	0.17	0.27	-0.24	0.27	-0.07	-0.38	-0.11		-0.16	-0.26	-0.35	0.06	-0.26	-0.26	0.39	-0.16	-0.31	-0.36	-0.26	-0.26	0.22
Property Plant Equipment	0.96	0.76	0.88	0.76	0.72	0.61	0.87	0.86	0.94	0.68	0.68	-0.16		0.94	0.75	0.09	0.76	0.17	-0.59	0.83	0.83	0.81	0.83	0.81	-0.16
Good Will	0.95	0.87	0.82	0.87	0.7	0.57	0.85	0.8	0.92	0.72	0.78	-0.26	0.94		0.8	0.03	0.8	0.22	-0.68	0.8	0.83	0.87	0.86	0.83	-0.2
Net Tangible Assets	0.79	0.94	0.58	0.93	0.62	0.33	0.82	0.61	0.81	0.86	0.49	-0.35	0.75	0.8		-0.17	0.71	0.27	-0.68	0.54	0.91	0.89	0.87	0.9	-0.57
Current Deferred Revenue	0.03	-0.06	0.01	-0.07	-0.22	-0.02	-0.01	-0.03	0.0	-0.22	0.16	0.06	0.09	0.03	-0.17		0.0	0.05	-0.04	-0.04	-0.22	-0.03	-0.13	-0.12	0.45
Short Term Investments	0.73	0.75	0.59	0.77	0.39	0.38	0.63	0.55	0.71	0.7	0.59	-0.26	0.76	0.8	0.71	0.0		0.15	-0.57	0.57	0.78	0.75	0.66	0.64	-0.23
Deferred Long Term Liab	0.26	0.34	0.02	0.26	0.19	-0.47	0.29	0.11	0.25	0.04	0.4	-0.26	0.17	0.22	0.27	0.05	0.15		-0.74	-0.04	0.13	0.25	0.07	0.09	-0.01
Short Long Term Debt	-0.69	-0.79	-0.39	-0.73	-0.47	0.17	-0.69	-0.47	-0.66	-0.43	-0.79	0.39	-0.59	-0.68	-0.68	-0.04	-0.57	-0.74		-0.28	-0.55	-0.8	-0.47	-0.48	0.17
Long Term Debt Total	0.73	0.54	0.83	0.61	0.59	0.81	0.57	0.74	0.71	0.73	0.37	-0.16	0.83	0.8	0.54	-0.04	0.57	-0.04	-0.28		0.73	0.55	0.85	0.79	-0.28
Capital Surpluse	0.78	0.84	0.66	0.87	0.64	0.51	0.76	0.67	0.8	0.92	0.42	-0.31	0.83	0.83	0.91	-0.22	0.78	0.13	-0.55	0.73		0.82	0.88	0.88	-0.6
Long Term Investments	0.86	0.93	0.64	0.92	0.58	0.27	0.83	0.65	0.83	0.73	0.75	-0.36	0.81	0.87	0.89	-0.03	0.75	0.25	-0.8	0.55	0.82		0.76	0.77	-0.36
Net Invested Capital	0.82	0.82	0.79	0.86	0.7	0.68	0.78	0.74	0.84	0.9	0.41	-0.26	0.83	0.86	0.87	-0.13	0.66	0.07	-0.47	0.85	0.88	0.76		0.99	-0.48
Net Working Capital	0.82	0.83	0.76	0.86	0.71	0.63	0.81	0.73	0.84	0.88	0.39	-0.26	0.81	0.83	0.9	-0.12	0.64	0.09	-0.48	0.79	0.88	0.77	0.99		-0.47
Capital Stock	-0.09	-0.39	-0.14	-0.42	-0.15	-0.16	-0.09	-0.15	-0.12	-0.73	0.14	0.22	-0.16	-0.2	-0.57	0.45	-0.23	-0.01	0.17	-0.28	-0.6	-0.36	-0.48	-0.47

Click cells to compare fundamentals

Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.

Competition

Predict Phibro Animal

Working Capital Over Time

Based on the company's disclosures, Phibro Animal Health has a Working Capital of 396.85 M. This is 6.77% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The working capital for all United States stocks is 73.15% higher than that of the company.

Phibro Working Capital Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Phibro Animal's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Phibro Animal could also be used in its relative valuation, which is a method of valuing Phibro Animal by comparing valuation metrics of similar companies.

Phibro Animal is currently under evaluation in working capital category among its peers.

Phibro Animal ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Phibro Animal's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Phibro Animal's managers, analysts, and investors.

Environmental

Governance

Social

Phibro Fundamentals

	Return On Equity	0.0655
	Return On Asset	0.0526
	Profit Margin	0.02 %
	Operating Margin	0.08 %
	Current Valuation	1.37 B
	Shares Outstanding	20.34 M
	Shares Owned By Insiders	0.57 %
	Shares Owned By Institutions	99.43 %
	Number Of Shares Shorted	404.72 K
	Price To Earning	11.39 X
	Price To Book	3.66 X
	Price To Sales	0.91 X
	Revenue	1.02 B
	Gross Profit	298.24 M
	EBITDA	84.61 M
	Net Income	2.42 M
	Cash And Equivalents	98.67 M
	Cash Per Share	2.44 X
	Total Debt	525.46 M
	Debt To Equity	1.79 %
	Current Ratio	2.97 X
	Book Value Per Share	6.38 X
	Cash Flow From Operations	87.59 M
	Short Ratio	2.28 X
	Earnings Per Share	0.43 X
	Price To Earnings To Growth	1.66 X
	Target Price	18.4
	Number Of Employees	1.94 K
	Beta	0.51
	Market Capitalization	947.38 M
	Total Asset	982.18 M
	Retained Earnings	243.89 M
	Working Capital	396.85 M
	Current Asset	342.83 M
	Current Liabilities	108.78 M
	Annual Yield	0.02 %
	Five Year Return	1.85 %
	Net Asset	982.18 M
	Last Dividend Paid	0.48

About Phibro Animal Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Phibro Animal Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Phibro Animal using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Phibro Animal Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

F	Ford Motor
GOOG	Alphabet Inc Class C
CRM	Salesforce

When determining whether Phibro Animal Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Phibro Animal's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Phibro Animal Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Phibro Animal Health Stock:

How To Invest In Phibro

Details

Is Phibro Stock a good investment?

Details

What is Phibro Animal's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Phibro Animal Piotroski F Score and Phibro Animal Altman Z Score analysis.

You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Phibro Animal. If investors know Phibro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Phibro Animal listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.94)

Dividend Share

0.48

Earnings Share

0.43

Revenue Per Share

25.843

Quarterly Revenue Growth

0.126

The market value of Phibro Animal Health is measured differently than its book value, which is the value of Phibro that is recorded on the company's balance sheet. Investors also form their own opinion of Phibro Animal's value that differs from its market value or its book value, called intrinsic value, which is Phibro Animal's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Phibro Animal's market value can be influenced by many factors that don't directly affect Phibro Animal's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Phibro Animal's value and its price as these two are different measures arrived at by different means. Investors typically determine if Phibro Animal is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Phibro Animal's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Phibro Animal Health Stock Working Capital

Phibro Animal Health Company Working Capital Analysis

Working Capital

Current Assets

-

Current Liabilities

Current Phibro Animal Working Capital

Phibro Working Capital Driver Correlations

Phibro Working Capital Peer Comparison

Phibro Animal ESG Sustainability

Phibro Fundamentals

About Phibro Animal Fundamental Analysis

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY